Specifications TableSubjectNatural Products ResearchSpecific subject areaBiochemistry, Biology, AgeingType of dataTable and FigureHow data were acquiredScreening bioactive compounds of *G. zeylanicum* leaf extracts.\
Conducting of antioxidant and anti-aging activities with *G. zeylanicum* leaf extracts in *C. elegans*.Data formatRaw and analyzed dataParameters for data collectionLeaf of *G. zeylanicum* was extracted in hexane and methanol solvents to investigate the bioactive compounds, antioxidant and anti-aging effects in *C. elegans*.Description of data collectionThe bioactive compounds of the extracts were analyzed using GLC-MS, LC-MS, and RP-HPLC. The antioxidant properties were determined using phenolics, flavonoids, ABTS and DPPH assays. The *in vivo* antioxidant properties were performed using the intracellular ROS accumulation and the survival rate under oxidative stress condition assays. The anti-aging properties were conducted using the brood size, body length and life-span assays.Data source location*G. zeylanicum* was collected from Jana, Songkhla, Thailand (6.8447° N, 100.6647° E). Plant extraction was done at Chulalongkorn University, Bangkok, Thailand (13.7323° N, 100.5368° E). GLC-MS and LC-MS were performed at University Kebangsaan Malaysia, Bangi, Malaysia (2.9300° N, 101.7774° E). Antioxidant and anti-aging properties in *C. elegans* were performed at Heidelberg University, Heidelberg, Germany (49.4191° N, 8.6702° E).Data accessibilityData are available within this articleRelated research articleChatrawee Duangjan, Panthakarn Rangsinth, Xiaojie Gu, Shaoxiong Zhang, Michael Wink, and Tewin Tencomnao, *Glochidion zeylanicum* leaf extracts exhibit lifespan extending and oxidative stress resistance properties in *Caenorhabditis elegans* via DAF-16/FoxO and SKN-1/Nrf-2 signaling pathways, Phytomedicine: international journal of phytotherapy and phytopharmacology, 2019; 64:153061, [https://doi.org/10.1016/j.phymed.2019.153061](10.1016/j.phymed.2019.153061){#intref0010}.**Value of the data**•This data provides novel bioactivity for medicinally important plant and supplement drugs against oxidative stress.•Data proved the natural plant leaf extracts can effectively exert both oxidative stress resistance and anti-aging properties in the *C. elegans* model and may lead to new agents to benefit humans in the near future.•This data provides information to researchers of herbal medicine for the discovery of new therapeutic applications of compounds from *G. zeylanicum*.•This data will help in further research to identify bioactive molecules from the crude extracts that possessed antioxidant and anti-aging activities.

1. Data {#sec1}
=======

The dataset in this study shows the potential of *Glochidion zeylanicum* leaf extracts (hexane and methanol) on lifespan extending and oxidative stress resistance properties in *Caenorhabditis elegans.* Bioactive compounds in GZ hexane and methanol extracts were analyzed by GLC-MS, LC-MS and HPLC ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}). *G. zeylanicum* leaf extracts showed antioxidant activities *in vitro* ([Table 4](#tbl4){ref-type="table"}, [Fig. 1](#fig1){ref-type="fig"}) and *in vivo* ([Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}). Moreover, *G. zeylanicum* leaf extracts have oxidative stress resistance properties ([Fig. 4](#fig4){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"}) and anti-aging in *C. elegans* ([Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"} and [Fig. 5](#fig5){ref-type="fig"}) [@bib1].Table 1Proposed phytochemical constituents in the GZ hexane extract using GLC-MS.Table 1Peak No.Rt (min)Area (%)Concen-tration[a](#tbl1fna){ref-type="table-fn"}Proposed compoundMatchProb.1430.98201.0160--Pentadecanoic acid75568.302033.128048.31803727.26n-Hexadecanoic acid or Palmitic acid89771.502634.76900.6850--Phytol79842.302935.942011.0570429.559,12,15-Octadecatrienoic acid, (Z,Z,Z)- or α-Linolenic acid8129.903136.263010.9150--Octadecanoic acid or Stearic acid90089.603839.35301.6730--Hexanedioic acid, mono(2-ethylhexyl)ester or Adipic acid80879.003940.36201.0370--Benzoic acid, 3-methyl-2-trimethylsilyloxy-, trimethylsilyl ester591607.00[^1][^2]Table 2Proposed phytochemical constituents in the GZ methanol extract using LC-MS.Table 2Peak No.Rt (min)\[M + H\]+ (m/z)Area (%)Proposed compoundTheoretical massMass error (ppm)111.8116.072313.9908L-Proline115.06335152.1242.10154.68035Resveratrol 4′-methyl ether219.11076172.3193.07001.34899Quinic acid192.06343296.4171.02901.72094Gallic acid170.02151418.7449.10923.81108Quercitrin or Kaempferol 3-alpha/beta-D-galactoside or Kaempferol 3-alpha/beta-D-glucoside448.10063479.1447.12721.73585Ginkgolide B424.13832489.1447.12943.08348Glycitin446.121317413.4290.846418.7542Catechin290.07901[^3]Table 3Individual phytochemical constituents in the GZ methanol extract using HPLC.Table 3Peak No.Rt (min)CompoundConcenration[a](#tbl3fna){ref-type="table-fn"}111.7Gallic acid2998.63221.1Catechin36714.74337.3Oxyresveratrol2.17441.8Quercetin8.33[^4]Table 4Total phenolic content, total flavonoid content and free radical scavenging capacity of GZ extracts.Table 4ExtractTotal Phenolics mg GAE/g[b](#tbl4fnb){ref-type="table-fn"}Total Flavonoids mg QE/g[b](#tbl4fnb){ref-type="table-fn"}DPPH scavenging assayABTS scavenging assay%Radical Scavenging activity[a](#tbl4fna){ref-type="table-fn"}EC~50~ (μg/mL)%Radical Scavenging activity[a](#tbl4fna){ref-type="table-fn"}EC~50~ (μg/mL)GZH7.33 ± 2.293.77 ± 1.3714.75 ± 3.02--21.64 ± 1.13--GZD8.49 ± 0.620.35 ± 0.2712.17 ± 2.56--22.50 ± 1.18--GZM162.81 ± 3.6446.96 ± 0.0986.66 ± 0.4465.27 ± 11.6393.98 ± 0.0563.45 ± 1.14Vitamin C------1.28 ± 0.12--1.38 ± 0.02EGCG------0.95 ± 0.08--0.95 ± 0.02[^5][^6][^7]Fig. 1ABTS radical scavenging activity of GZM (15.625--2000 μg/mL) (A), ABTS radical scavenging activity of EGCG and vitamin C (0.3125--20 μg/mL) (B). DPPH radical scavenging activity of GZM (15.625--2000 μg/mL) (C), DPPH radical scavenging activity of EGCG and vitamin C (0.3125--20 μg/mL) (D). Values are expressed as the mean ± SD (n = 3).Fig. 1Fig. 2Representative pictures of DCFDA fluorescence in worms treated with 25 μg/mL GZH (A); 50 μg/mL GZH (B); 100 μg/mL GZH (C); 1 μg/mL GZM (D); 2.5 μg/mL GZM (E); 5 μg/mL GZM (F); DMSO solvent control (G); and 25 μg/mL EGCG (H).Fig. 2Fig. 3Effect of GZ extracts on the intracellular ROS of CF1038 (A) and EU1 (B) worms.Fig. 3Fig. 4Effect of GZ extracts on the survival rate of CF1038 (A) and EU1 (B) worms under oxidative stress induced by juglone.Fig. 4Table 5Effect of GZ extracts on markers of aging and development in *C. elegans*.Table 5ExtractBrood size(mean egg lay)Body length (mean length (μm))DMSO reagent control245.5 ± 33.501517 ± 18.9725 μg/mL GZH273.3 ± 22.871417 ± 19.9350 μg/mL GZH251.3 ± 15.121444 ± 27.13100 μg/mL GZH288.8 ± 2.4961460 ± 37.3725 μg/mL GZD272.8 ± 15.191444 ± 36.7850 μg/mL GZD274.3 ± 15.881889 ± 434.9100 μg/mL GZD247.3 ± 9.3221500 ± 15.301.0 μg/mL GZM228.0 ± 13.451417 ± 18.382.5 μg/mL GZM222.0 ± 11.001542 ± 18.555 μg/mL GZM231.3 ± 8.1591442 ± 47.51[^8][^9]Table 6Results and statistical analyses of GZ extracts treated *C. elegans* in lifespan assay.Table 6StrainTreatmentMean lifespan (day) ± SEMMaximum lifespan (days)Percentage of increased lifespan (vs control)P value (vs control)P value summaryNumber of wormsN2DMSO control14.28 ± 0.359921N = 120N225 μg/mL GZH13.93 ± 0.350724−2.450980.901nsN = 121N250 μg/mL GZH14.21 ± 0.380524−0.4901960.833nsN = 105N2100 μg/mL GZH15.71 ± 0.54863210.0140060.0056\*\*N = 132N21.0 μg/mL GZM15.42 ± 0.4908297.98319330.0139\*N = 127N22.5 μg/mL GZM12.55 ± 0.448929−12.114850.7191nsN = 112N25 μg/mL GZM15.53 ± 0.4635348.75350140.0066\*\*N = 132TK22DMSO control9.667 ± 0.414415N = 33TK2225 μg/mL GZH9.429 ± 0.412616−2.461984070.6491nsN = 35TK2250 μg/mL GZH9.581 ± 0.352515−0.8896244960.816nsN = 31TK22100 μg/mL GZH10.37 ± 0.5288177.2721630290.4833nsN = 27TK221.0 μg/mL GZM11.54 ± 0.52451719.375193960.1071nsN = 39TK222.5 μg/mL GZM11.31 ± 0.52361816.995965660.1798nsN = 39TK225 μg/mL GZM10.88 ± 0.50151712.547843180.4237nsN = 41[^10][^11]Fig. 5(A) Brood size and (B) body length of N2 (wt) worms after GZ extracts treatment. GZ extracts have no effect on egg laying activity and body length. Data are presented as the mean ± SEM (n = 80, replicated three times). Treatment groups are compared to the DMSO control by one-way ANOVA following Bonferroni\'s method (posthoc).Fig. 5Fig. 6Effect of GZ extracts at low concentrations on the intracellular ROS (A-B) and the survival rate (C-D) of wild-type (N2) worms.Fig. 6

Bioactive compounds in GZ hexane extract was analyzed by GLC-MS, The secondary metabolites from GZ hexane extract contains pentadecanoic acid, n-hexadecanoic acid, phytol, octadecatrienoic acid, octadecanoic acid, hexanedioic acid and benzoic acid.

Bioactive compounds in GZ methanol extract was analyzed by LC-MS, The secondary metabolites from GZ methanol extract contains l-proline, resveratrol 4′-methyl ether, quinic acid, gallic acid, quercitrin/kaempferol 3-alpha-d-glucoside, ginkgolide b, glycitin, and catechin.

The GZ methanol extract exhibited powerful antioxidant activity. When tested in the DPPH and ABTS assays, GZ methanol extract effectively scavenged the radical by 86.66% (EC50 = 65.27 μg/mL) and 93.98% (EC50 = 1.38 μg/mL), respectively. In accordance with the antioxidant activities, high phenolic and flavonoid contents of 162.81 GAE/g dry weight sample and 46.96 QE/g dry weight sample were recorded from the methanol extract.

GZ extracts showed lower levels of ROS in N2 worms when compared to the DMSO control group. DMSO and EGCG were used as a solvent control and positive control group, respectively.

GZ extracts failed to decrease the level of ROS in CF1038 and EU1 worms. DMSO and EGCG were used as the solvent control and positive control groups, respectively. Data are presented as the mean ± SEM (n = 80, replicated three times). Treatment groups are compared to the DMSO control by one-way ANOVA following Bonferroni\'s method (posthoc).

GZ extracts failed to increase the survival rate in CF1038 and EU1 worms under oxidative stress condition. Data are presented as the mean ± SEM (n = 80, replicated three times). Treatment groups are compared to the DMSO control by one-way ANOVA following Bonferroni\'s method (posthoc).

GZ extracts at low concentrations (5--10 μg/mL GZH and 0.25--0.5 μg/mL GZM) failed to neither decrease the level of ROS nor increase the survival rate in wild-type worms. DMSO was used as the solvent control. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 and \*\*\*\*p \< 0.0001, compared to the DMSO control by one-way ANOVA following Bonferroni\'s method (posthoc). Data are presented as the mean ± SEM (n = 80, replicated three times).

The lifespan assay was carried out with wild-type (N2) and mev-1(kn-1) worms at 20 °C. P-value log rank as compared to the control worms; the mean lifespan in days is the average number of days the worms survived in each group. Each treatment was compared to the control by the non-parametric log rank (Mantel−Cox) tests.

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Qualitative phytochemical screening {#sec2.1}
----------------------------------------

For GLC-MS, chromatographic separation was carried out on a Clarus 600 GC-MS system (Perkin Elmer, Shelton, CT, USA) separated with a 30 m × 0.25 mm × 0.25 μm Elite-5MS column (Perkin Elmer, USA). Plant extracts were incubated in MeOX and pyridine at 40 °C for 90min at 40 °C. Then, the MSTFA (N-Methyl-N-(trimethylsilyl) trifluoroacetamide) were added to the sample and incubated for 90min at 40 °C. The temperature of the oven was set at 40 °C and was increased by 5 °C/min until it reached 250 °C, and the carrier gas was helium at a constant flow of 1 mL/min. The MS parameters used were electron impact mode (EI) following an ionization voltage of 70 eV, an ion source temperature of 200 °C and a scan range of 40--600 Da.

The National Institute of Standards and Technology (NIST, version 2.0, Gaithersburg, MD, USA) database was used for the identification of top ten compounds by exceeding the signal-to-noise ratio (S/N) of 100 and comparing the volatile information based on the compound name. Match and reverse match values below 800 were filtered.

For LC-MS, chromatographic separation was carried out on a Dionex™ UltiMate 3000 UHPLC system (Thermo Scientific) equipped with an Acclaim™ Polar Advantage II C18 column (3 × 150 mm, 3 μm particle size) (Thermo Scientific, USA) by using a 1 μL injection volume. The mobile phase comprised 0.1% formic acid in water (solvent A) and 100% acetonitrile (solvent B), which had a flow rate of 400 μL/min for 22 min. At 0--3 min, 3--10 min, 10--15 min, and 15--22 min; 5% B, 80% B, 80% B, and 5% B were used for the gradient elution, respectively. High-resolution MS analysis was carried out in the positive electrospray ionization mode using a MicrOTOF-Q III (Bruker Daltonik GmbH, Bremen, Germany). A capillary voltage of 4500 V, drying gas flow of 8 L/min, an ion source temperature of 200 °C, a nebulizer pressure of 1.2 bar, an end plate offset of −500 V, and a scan range from *m*/*z* 50 to 1000 were used as parameters for the instrument. The METLIN and KNApSAcK databases were used for identification of top ten compounds by comparing the observed *m*/*z* values with the calculated mass values from previously published data. The abundance of individual compounds was calculated from the percentage of peak area relative to the total area of all peaks in the chromatograms.

For HPLC, the chromatography was carried out on SHIMADZU LC-10 HPLC equipped with an analytical C18 reversed-phase column (ODS3 C18, 4.6 × 250 mm i.d., 5-μm particle size) and UV detector (best condition at 220 nm). The mobile phase consists of 0.02 M sodium acetate, buffered to a pH of 4 with 0.0125 M citric acid, containing 0.042 M methanesulfonic acid and 0.1 mM EDTA. The flow rate was set at 1 mL/min. The working standard solutions were freshly prepared in 0.05 M perchloric acid containing 0.1 mM Na~2~EDTA on ice and stored at −20 °C before using. Peaks were identified by comparing the retention time of each peak in the sample solution, where each individual peak was further compared to the standard solution of gallic acid, catechin, oxyresveratrol, quercetin, octadecatrienolic acid (linolenic acid), and hexadecanoic (palmitic acid) (Sigma-Aldrich, USA) served as an internal standard. The calibration curves of internal standard compounds were constructed for quantification.

2.2. Assessment of resistance to oxidative stress {#sec2.2}
-------------------------------------------------

The wild-type (N2) and transgenic (*daf-16 (mu86)* mutant CF1038, *skn-1(zu67)* mutant EU1) worms were used for analysis the survival rate under oxidative stress conditions, 80 worms at L1 larval stage were treated with plant extracts with different concentrations in S-medium for 48 h, each group contained 80 larvae. Each group was treated with 80 μM pro-oxidant juglone for 24 h. Then dead and live worms were counted.

2.3. Assessment of intracellular ROS {#sec2.3}
------------------------------------

Worms were treated with plant extracts of different concentrations in S-medium for 48 h; each group comprised 50--100 larvae. After treatment, the worms were pelleted by centrifugation, added to 50 μM 2,7-dichlorodihydrofluorescein-diacetate (H~2~DCF-DA) solution and incubated in the dark at 20 °C for 1 h. After incubation, worms were paralyzed using 10 mM sodium azide and mounted on a microscopic glass slide; then, photos were taken randomly of 30 worms.

2.4. Expression of HSP-16.2, GST-4 and SOD-3 {#sec2.4}
--------------------------------------------

50-100 worms at L1 larval stage of transgenic worms were treated with different concentrations of plant extracts in S-medium at 20 °C for 72 h (TJ375 and CF1553 transgenic worms) and 48 h (CL166 transgenic worms). After treatment, TJ375 and CL166 transgenic worms were exposed to a nonlethal dose of 20 μM juglone for 24 h. The fluorescence intensity was measured by fluorescence microscopy as described above.

2.5. Subcellular DAF-16 and SKN-1 localization {#sec2.5}
----------------------------------------------

50-100 worms at L1 larval stage of transgenic worms were treated with different concentrations of plant extracts in S-medium at 20 °C for 72 h. And the fluorescence intensity was measured by fluorescence microscopy as described above.

2.6. Assessment of auto fluorescent pigment {#sec2.6}
-------------------------------------------

50-100 worms at L1 larval stage of BA17 transgenic worms were treated with different concentrations of plant extracts in S-medium at 25 °C. The media was changed every second day. On day 16, the worms were paralyzed with 10 mM sodium azide, mounted on a glass slide and photographed.

2.7. Assessment of pharyngeal pumping rate {#sec2.7}
------------------------------------------

Synchronized N2 worms at the L4 larval stage were sorted and placed one by one on individual NGM agar plates supplemented with plant extracts with different concentrations with an *E. coli* OP50 lawn as a food source at 20 °C for 24 h. (50 worms per each group). The adult worms were transferred to fresh medium every day during the reproductive phase to separate them from their progeny. After that, the adult worms were transferred to fresh medium with treatment every second day. Pharyngeal pumping was analyzed on days 6, 8, 10, and 12 by counting the pumping frequency of the terminal pharyngeal bulb of each single worm for 60 s. The dissection microscope was used to measure the pumping rate of at least 20 worms from each group. When the worms were crawling on the *E. coli* OP50 lawn, the pumping frequency was recorded and represented as pumps min^−1^.

2.8. Assessment of lifespan {#sec2.8}
---------------------------

The wild-type (N2) and transgenic (TK22) (A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and short lifespan) [@bib2] worms were used for the lifespan assay. Synchronization and treatment were conducted as in the pharyngeal pumping rate assay. The worms were counted every day and documented as a percentage of surviving worms. Worms that failed to respond to a gentle touch with a platinum wire were scored as dead and excluded from the plates. The worms with internally hatched progeny or extruded gonads were scored as censors and discarded from the assay.

2.9. Assessment of antioxidant activity {#sec2.9}
---------------------------------------

The total phenolic and flavonoid content were examined by the Folin - Ciocalteau method and colorimetric aluminum chloride method as described previously [@bib3]. The DPPH and ABTS radical scavenging assays were conducted according to the method followed in our previous work [@bib3].
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[^1]: Library: MAINLIB.

[^2]: mg/100 g of crude extract.

[^3]: Database: METLIN (CA, USA) and KNApSAcK Keyword Search Web Version 1.000.01.

[^4]: mg/100 g of crude extract.

[^5]: GZH; 1 mg/mL of GZ hexane extract, GZD; 1 mg/mL GZ dichloromethane extract, GZM; 1 mg/mL GZ methanol extract.

[^6]: Of 1 mg/mL extract.

[^7]: Dry weight sample, Values are expressed as the mean ± SD (n = 3).

[^8]: (Results are the means ± SEM).

[^9]: GZH; GZ hexane extract, GZD; GZ dichloromethane extract, GZM; GZ methanol extract.

[^10]: N2; Wild-type, TK22; mev-1(kn1).

[^11]: GZH; GZ hexane extract, GZM; GZ methanol extract.
